We would love to hear your thoughts about our site and services, please take our survey here.
Anybody heading in the direction of dunblane ,looking for a program, professor Jeff Evans will attend this meeting:
https://www.eventbrite.co.uk/e/ecmc-1st-annual-pan-scotland-meeting-tickets-801149418477
Best comment wins
https://investingstrategy.co.uk/biotech/every-medical-leap-forward-is-really-just-one-of-many-small-steps/
Https://www.stockopedia.com/content/fund-manager-interview-with-oliver-brown-of-rc-brown-highlighting-20-stock-ideas-991810/
Is this link ok because I am on the move
..The very strong in-solution binding of affimers to Pertuzmab had been previously reported and stands in agreement with the results from our work..
..Immuno-analytical techniques
hold the promise to perform the requested challenging tasks [61], and new types of specific
binders, such as affimers, shall unquestionably find their position in the toolbox, which
should be well equipped for finding the indicators of specific illnesses or the markers that
inform the physician whether or not a drug has reached its optimal treatment levels, i.e.,
the optimal concentrations in the patient’s blood, in other words: the targeted therapeutic
signature..
https://programme.conventus.de/dgms-2024/program/program-points/7c31423e-7499-4aef-b0bf-a439d2cc35fa
https://acrobat.adobe.com/id/urn:aaid:sc:EU:4279f9d7-e166-4299-bd44-bc1a6cb045cc
Since we are having a quiet monday, I am going to repost this interview.Are we part of this success story ?
" I never thought I would say that. Many folks have tried to relegate chemotherapy to the museum, but last year it came to the forefront"
Mark Kris from Memorial Sloan Kettering
https://youtu.be/eq8wMGi5UvM?feature=shared
Spooky similarity 😳
Believe it or not, shortbread isn't a bread at all, but rather, a biscuit. The name can be attributed to the fact that the government once placed taxes on biscuits; so, to dodge the taxes, Scottish bakers labeled the pastry as bread
D-Geeman,thank you for your contribution.I must admit I was not aware of this "crunching"information.
Btw ,
I didn't even finish it because it was full of biscuits. I thought I was going to be smart and use 2 biscuits at once to rescue the singles but it didn't go to plan.
I should have used a more robust biscuit
..Sigh ...
"The most important drugs in oncology are all approved at excessive doses," says Ratain.
Regulators are also starting to pay attention to the problem. The FDA's request to Amgen on sotorasib is part of the agency's Project Optimus to reform the dose-selection paradigm in oncology drug development. The agency has been collaborating with companies, academia and patients to encourage dose regimens that maximize not only the efficacy of a drug but also its safety and tolerability."
Seemed like an interesting article
I was able to open it (for free) for a short time, , but now I can't
😏
https://www.nature.com/articles/s41591-024-02845-7